Sunday 11 October 2026 Export all LLY data to Excel Powerpack

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,179.27 9.67 +0.83%
Market cap
$1.10T
P/E
39.6×
Fwd P/E
33.1×
Dividend yield
0.57%
F-score
7/9
Altman Z
8.61
Beneish M
−1.91
Dividend safety
86/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

37.33 46.83 32.67 40.25
P/S ratio
11.52 14.79 11.39 13.44
P/FCF ratio
59.65 86.31 58.67 52.49
P/Operating CF
77.45 299.05 154.27 100.13
P/B ratio
28.69 36.34 26.37 31.59
Price to Tangible BV
59.48 68.31 46.50 154.68
EV/Sales
12.13 15.34 11.88 14.01
EV/EBITDA
29.38 35.32 25.58 31.24
EV/Operating CF
44.89 59.45 41.92 39.75
EV/FCF
62.85 89.46 61.21 54.75
Quick Ratio
0.73 0.78 0.72 0.68
Current Ratio
1.55 1.58 1.50 1.35
Net Debt/EBITDA
3.95 3.93 3.62 4.83
Debt/Assets
35.56% 37.79% 33.77% 38.59%
Debt/Equity
1.71 1.60 1.26 1.62
Asset Turnover
0.62 0.68 0.70 0.66
Operating CF/Net income
1.58 0.49 0.72 1.51
Capex/Depreciation
(4.44) (4.35) (4.57) (5.49)
Research and Development Expense of Revenue
19.69% 19.70% 17.73% 16.62%
Selling, General and Administrative Expense of Revenue
15.57% 16.24% 14.82% 14.93%
Intangible Assets out of Total Assets
0.11 0.11 0.12 0.19
Share Based Compensation of Revenue
0.86% 0.71% 0.81% 0.87%
Graham Net Nets
(0.04) (0.03) (0.04) (0.04)
Graham Number
110.59 123.57 148.63 159.55
Earnings Yield
2.68% 2.14% 3.06% 2.48%
Free Cash Flow Yield
1.68% 1.16% 1.70% 1.91%
Revenue per Share
19.62 21.50 22.13 25.74
Operating CF per Share
9.85 3.59 5.96 11.98
Capex per Share
(2.33) (2.84) (2.60) (3.29)
Free Cash Flow per Share
7.52 0.76 3.36 8.69
Cash per Share
11.05 8.10 5.91 10.03
Shareholders Equity per Share
26.59 29.57 34.88 37.96
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
26.59 29.57 34.88 37.96
Free Cash Flow
6,748.10 677.90 3,007.00 7,757.00
Working Capital
21,930.40 20,401.00 18,201.00 16,931.00
Capital Expenditures
(2,087.30) (2,546.70) (2,326.00) (2,933.00)
Net Current Asset Value
(29,013.30) (30,312.00) (30,543.00) (43,732.00)
EV/EBIT
31.85 38.00 27.23 33.19
Capex to Sales
0.12 0.13 0.12 0.13
Price to Operating Income
30.23 36.66 26.10 31.83
Other line items
Average Receivables
15,754.45 16,715.50 17,590.10 20,340.30
Average Payables
3,574.35 4,304.00 4,235.50 5,093.85
Average Inventory
9,820.10 10,666.50 11,920.00 13,903.40
Average Assets
95,271.15 95,595.50 102,982.40 121,602.80
Average Common Equity
19,085.75 20,403.50 23,522.40 26,114.05

Fold the line items

Columns are period end dates